Blood pressure
33 supplements analyzed and ranked by clinical evidence.
Supplement Evidence
BP β, Kβ
BP β, Kβ
BPβ,HRβ
BPβ,ephedrineβ
BPβ 8β13 mmHg
Spikesβ; 48% fewer
Nitrate markersβ BP -8/β4
Tolerance: BPβ then wanes
Sildenafil amplifies nitrate hypotension
BPβ ~3-7 mmHg
BPβ with omega-3
SBP/DBPβ
TGβ +5-15 mmHg
BPβ, TGβ
BP β 3-6 mmHg
DHA stronger β BP
SBP/DBP β, HR β
Vasodilation, β10 mmHg
Renal flow, β29%
SBP β 5-12
DBP β 4-13
SBP β15 to β22
DBP β4 to β12
SBP β12 mmHg
DBP β5 mmHg
Hypertension risk β36%
SBP β7 to β14
DBP β14%
SBP/DBP β 10/7 mmHg
DBP β 4 mmHg
BP β, NOβ
Stress BP β, AIxβ
BP fall reduced, +4.5
SBP/DBP lowered, -7 to -8
Standing BP raised, +5.9
SBP β5β7 mmHg
DBP lowered
BP β 9β15 mmHg
Stress BP β ~15%
Central BP/stiffness β
BP -11.2 mmHg
BP decreased significantly
BP lowered, safe
Blood pressure β
MAP β10 mmHg
SBP/DBP β ~6-13
Metabolic markers β
SBP/DBP β ~7 mmHg
Dose-dependent BP β
BP β5-10 mmHg
LDL β22-24%
Diastolic BP -4.8 mmHg
Home BP -1.8/-1.5 mmHg
SBP β3β7 mmHg
BP meds β50%
Clinic & ambulatory BP β
SBP β7.2 mmHg
DBP β4.7 mmHg
BP β SBP -14
BP β SBP/DBP
Arterial stiffness β
SBP β5.6, DBP β2.8
Renin activity β1.17
BP β8 mmHg
Aortic BP β10.4
BP lowered
BP - significant
BP decreased
BP slight edge
SBP β7 mmHg
24-h BP down
DBP lower
Arterial hemodynamics improved
BP down: -25/-11/-16
Fibrinolysis improved